Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.

Microbial diversity in the gut of people with rheumatoid arthritis is significantly reduced compared to that of the healthy individual, a new study shows.

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune cells attacking the joints and can result in pain, swelling, and damage to ...

Rooney said these findings may one day lead to new treatment options for rheumatoid arthritis. “Our findings suggest that certain bacteria in the gut microbiome may be involved in triggering the ...

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to researchers.

Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.

According to a 2018 review of treatment approaches for rheumatoid arthritis, the type of surgery a person has may depend on their individual needs and disease progression. Doctors may use the ...

Many natural ... like rheumatoid arthritis, early diagnosis allows for the use of DMARDs (disease-modifying antirheumatic drugs) that can slow disease progression. Starting treatment in the ...

University of Leeds-led research has identified specific changes in the gut microbiome of individuals at risk of rheumatoid arthritis, potentially discovering disease onset mechanisms.

Among patients with rheumatoid arthritis, JAK inhibitors were slightly more effective for reducing pain at 3 and 12 months when compared with TNF inhibitors.